Tubeless Insulin Pump Market Size

Tubeless Insulin Pump Market size was valued at USD 11.9 billion in 2023 and is anticipated to reach USD 97.9 billion by the end of 2036, registering around 19.2% CAGR during the forecast period i.e., between 2024-2036. In 2024, the industry size of tubeless insulin pump is assessed at USD 14.1 billion.

The tubeless insulin market is driven by the rising incidence of type 1 diabetes across the globe. In 2022, a report published by the National Library of Medicine, the incidence of type 1 diabetes has drastically increased after the COVID-19 pandemic. Tubeless insulin pumps are cost-effective, user-friendly, and can be worn beneath any garment. As per a World Health Organization (WHO) report published in 2022, the world population is aging, and by 2050, 22% of the world population will be 60 years or above.

Manufacturers across the globe are focused on improving the accuracy and user-friendliness of tubeless insulin pumps to gain standard approvals for commercialization. For instance, the first automated tubeless insulin pump, Insulet’s Omnipod 5, received FDA approval in January 2022. Omnipod 5 is the first product that can be controlled via smartphone. Such ongoing groundbreaking innovations are expected to boost tubeless insulin pump market growth going ahead.